Replimune (REPL) Accounts Payables (2018 - 2026)
Replimune (REPL) reported Accounts Payables of $6.7 million for Q1 2026, down 46.47% on a YoY basis from $12.5 million in Q1 2025, and up 18.13% sequentially from $5.6 million in Q4 2025.
Replimune (REPL) Accounts Payables (2018 - 2026) Analysis & Trends
Replimune (REPL) has 9 years of Accounts Payables data on file, last reported at $6.7 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 46.47% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (down 46.47% YoY), and the FY2026 full-year result was $6.7 million, down 46.47% from the prior year.
- Accounts Payables advanced to $6.7 million in Q1 2026, from $5.6 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $15.5 million in Q2 2025 to a low of $864000.0 in Q2 2024.
- A 5-year average of $5.9 million and a median of $4.9 million in 2023 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables tumbled 82.31% in 2024 and jumped 1692.01% in 2025, its largest moves.
- Tracing REPL's Accounts Payables over 5 years: stood at $3.6 million in 2022, then increased by 6.99% to $3.9 million in 2023, then jumped by 84.17% to $7.2 million in 2024, then dropped by 21.44% to $5.6 million in 2025, then advanced by 18.13% to $6.7 million in 2026.
- Business Quant data shows REPL's Accounts Payables at $6.7 million in Q1 2026, $5.6 million in Q4 2025, and $6.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 6.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.67 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 15.48 Mn |
| Mar 31, 2025 | 12.46 Mn |
| Dec 31, 2024 | 7.19 Mn |
| Sep 30, 2024 | 8.41 Mn |
| Jun 30, 2024 | 864,000.00 |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 4.37 Mn |
| Jun 30, 2023 | 4.88 Mn |
| Mar 31, 2023 | 5.36 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 4.48 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Dec 31, 2021 | 3.92 Mn |
| Sep 30, 2021 | 3.15 Mn |
| Jun 30, 2021 | 2.38 Mn |